Koye Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 32.00 Cr
- Paid Up Capital ₹ 26.93 Cr
- Company Age 11 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 123.45 Cr
- Satisfied Charges ₹ 127.76 Cr
- Revenue Growth -9.81%
- Profit Growth -346.88%
- Ebitda -565.48%
- Net Worth -387.60%
- Total Assets -8.79%
About Koye Pharmaceuticals
Koye Pharmaceuticals Private Limited (KPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 12 May 2013 and has a history of 11 years and eight months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 32.00 Cr and a paid-up capital of Rs 26.93 Cr.
The company currently has active open charges totaling ₹123.45 Cr. The company has closed loans amounting to ₹127.76 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Koye Pharmaceuticals Private Limited India is Mitali Kulkarni as COMPANY SECRETARY. Ravindra Shenoy and Preetish Toraskar serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U74120MH2013PTC243214
- Company No.
243214
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 May 2013
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
What products or services does Koye Pharmaceuticals Private Limited offer?
Koye Pharmaceuticals Private Limited offers a wide range of products and services, including Health Conditions, Pain Relief, Respiratory Care, Health Food & Drinks, Healthy Snacks, Bone, Joint & Muscle Care, Immunity Boosters, Vitamin C, Popular Category, Bone & Joint Care.
Who are the key members and board of directors at Koye Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Mitali Kulkarni | Company Secretary | 23-Jan-2019 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Preetish Toraskar  | Director | 09-Sep-2013 | Current |
| Ravindra Shenoy | Director | 16-Jul-2013 | Current |
Financial Performance of Koye Pharmaceuticals.
Koye Pharmaceuticals Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 9.81% decrease. The company also saw a substantial fall in profitability, with a 346.88% decrease in profit. The company's net worth observed a substantial decline by a decrease of 387.6%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Koye Pharmaceuticals?
In 2023, Koye Pharmaceuticals had a promoter holding of 99.90% and a public holding of 0.10%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Koye Lifesciences Private LimitedRavindra Shenoy and Preetish Toraskar are mutual person
- Koye Foundation
Ravindra Shenoy and Preetish Toraskar are mutual person
Wealthurn Enterprises LlpRavindra Shenoy is a mutual person
- Koye Enterprises Llp
Ravindra Shenoy and Preetish Toraskar are mutual person
- Wealthurn Estates Llp
Ravindra Shenoy is a mutual person
- Blue Oyster Enterprises Llp
Ravindra Shenoy and Preetish Toraskar are mutual person
Charges (Loans)
₹123.45 Cr
₹127.76 Cr
Charges Breakdown by Lending Institutions
- Others : 56.85 Cr
- Axis Bank Limited : 41.60 Cr
- Yes Bank Limited : 22.00 Cr
- Tjsb Sahakari Bank Limited : 3.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Feb 2023 | Others | ₹20.00 Cr | Open |
| 22 Mar 2022 | Others | ₹36.85 Cr | Open |
| 22 Feb 2022 | Yes Bank Limited | ₹14.00 Cr | Open |
| 14 Jan 2022 | Tjsb Sahakari Bank Limited | ₹3.00 Cr | Open |
| 26 Oct 2021 | Axis Bank Limited | ₹15.00 Cr | Open |
How Many Employees Work at Koye Pharmaceuticals?
Koye Pharmaceuticals has a workforce of 673 employees as of Jan 23, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Koye Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Koye Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
